Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Accretive Health, Inc.    

SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Accretive Health, Inc. : Accretive Health Reports Inducement Grant under NYSE Rule 303A.08

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/04/2013 | 01:05pm CEST

Accretive Health, Inc. (NYSE: AH) today announced that pursuant to the employment agreement entered into with Stephen Schuckenbrock on April 2, 2013, the company granted to Mr. Schuckenbrock on April 3, 2013 a non-qualified stock option under the New York Stock Exchange inducement grant exception. The inducement grant was approved by the company's Board of Directors on April 1, 2013 and is being made as an inducement material to Mr. Schuckenbrock's acceptance of employment with the company, in accordance with New York Stock Exchange Rule 303A.08. The company previously announced that Mr. Schuckenbrock has been appointed President and Chief Executive Officer and a member of the company's Board of Directors, effective April 3, 2013.

The stock option is for the purchase of 2,903,801 shares of the company's common stock, with an exercise price of $9.56, which was the closing price of the company's common stock reported on the New York Stock Exchange on April 3, 2013. The stock option will vest and become exercisable on a ratable monthly basis over 48 months based on continued service to the company, subject to acceleration in specified circumstances.

Accretive Health is providing the above information regarding Mr. Schuckenbrock's inducement grant in accordance with New York Stock Exchange Rule 303A.08.

About Accretive Health

At Accretive Health, our mission is to help our healthcare clients strengthen their financial stability and deliver better care at a more affordable cost to the communities they serve (increasing healthcare access to all). For more information, visit www.accretivehealth.com.

Accretive Health, Inc.
Investor Relations:
Atif Rahim
Telephone: 312.324.5476
email: investorrelations@accretivehealth.com
or
Media:
Puneet Singh
Telephone: 330.565.6802
email: mediarelations@accretivehealth.com


© Business Wire 2013
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ACCRETIVE HEALTH, INC.
08/07 R1 RCM INC. (OTCMKTS : ACHI) Files An 8-K Results of Operations and Financial Co..
08/07 R1 RCM INC. : Results of Operations and Financial Condition, Financial Statement..
08/03 R1 RCM : Appoints Gary Long as Chief Commercial Officer
08/02 R1 RCM : Management's Discussion and Analysis of Financial Condition and Results..
08/02 R1 RCM INC. : Results of Operations and Financial Condition, Financial Statement..
08/02 R1 RCM INC. (OTCMKTS : ACHI) Files An 8-K Results of Operations and Financial Co..
08/02 R1 RCM Reports Second Quarter 2017 Results
08/02 R1 RCM : Central Maine Healthcare Selects R1 for Revenue Capture Solutions
08/02 R1 RCM Appoints Gary Long as Chief Commercial Officer
08/01 Central Maine Healthcare Selects R1 for Revenue Capture Solutions
More news
Financials ($)
Sales 2017 437 M
EBIT 2017 -26,2 M
Net income 2017 -26,7 M
Finance 2017 13,7 M
Yield 2017 -
P/E ratio 2017 -
P/E ratio 2018 214,67
EV / Sales 2017 0,74x
EV / Sales 2018 0,48x
Capitalization 338 M
Income Statement Evolution
Consensus
 
Mean consensus HOLD
Number of Analysts 3
Average target price 4,68 $
Spread / Average Target 45%
EPS Revisions
Managers
NameTitle
Joseph Gerard Flanagan President, Chief Executive Officer & Director
Steve J. Shulman Chairman
Tom Lesica Chief Operating Officer & Executive Vice President
Christopher Simon Ricaurte Chief Financial Officer & Treasurer
Alex J. Mandl Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
ACCRETIVE HEALTH, INC.338
FRESENIUS-6.29%45 441
FRESENIUS MEDICAL CARE-1.65%28 665
HCA HEALTHCARE INC7.07%28 535
LABORATORY CORP. OF AMERICA HOLDINGS21.86%16 024
QUEST DIAGNOSTICS INC16.00%14 561